Apixaban in Hemodialysis

Clinical trial NCT02672709 · COMPLETED

Trial details

NCT number: NCT02672709
Sponsor: Jewish General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

End-stage Renal Disease

Start date: 2016-04-01
Primary completion: 2016-08-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.